Delivery Order SPE2DB24D2205-SPE2DB25FDZCP
Award Date
3/4/25
Potential Completion Date
3/5/25
Potential Value
$5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,796.88 firm-fixed-price delivery order is for the supply of VISIPAQUE 320 MG/ML BOTTLE 100ML, a medical product. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $1,118.34 firm fixed price delivery order is for the supply of VISIPAQUE 320 MG/ML BOTTLE 100ML, a specialty pharmaceutical product. The award is part of a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 through December...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,053.00 firm fixed-price delivery order is for VISIPAQUE 320 MG/ML BOTTLE 100ML, a medical product used in healthcare settings. The contract has an ultimate completion date of February 3, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,236.68 firm fixed-price delivery order is for the supply of VISIPAQUE 320 MG/ML BOTTLE 100ML, a pharmaceutical product. The contract has an ultimate completion date of July 18, 2024 and was awarded on July 17, 2024. This contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,002.68 Firm Fixed Price contract is for the delivery of VISIPAQUE 320 MG/ML BOTTLE 100ML, a medical product. This contract does not have a set-aside designation, indicating open competition. The award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order valued at $1,687.64 with a firm fixed price and an ultimate completion date of November 20, 2024. The contract is for the supply of VISIPAQUE 320 MG/ML INFUS BTL 150ML, a pharmaceutical product. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
This federal contract award is for the delivery of VISIPAQUE 320 MG/ML INFUS BTL 150ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $1,687.64, was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and Veterans Affairs (VA) healthcare systems. The award is a delivery order placed under...
This federal contract award, valued at $2,699.62, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VISIPAQUE 320 MG/ML BOTTLE 100ML, a medical commodity used in federal healthcare programs. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of December 5, 2024. This award is associated with a larger...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,845.73 Firm Fixed Price Delivery Order is for the supply of VISIPAQUE 320 MG/ML BOTTLE 100ML, a medical product, to support military treatment facilities and programs. The contract has an ultimate completion date of August 15, 2024 and was awarded on August 14, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $2,725.09 firm fixed-price delivery order is for the supply of VISIPAQUE 320 MG/ML BOTTLE 100ML, a pharmaceutical product. The contract has an ultimate completion date of February 23, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves as a key vendor for federal healthcare programs, particularly within...